26
Participants
Start Date
December 23, 2013
Primary Completion Date
March 1, 2022
Study Completion Date
March 1, 2022
nutritional and functional assessments
"Patients will undergo nutritional \& functional assessments along the continuum of their chemoradiotherapy treatment. The initial assessment will be measurements of height, weight, \& baseline weight loss. Patients will receive chemotherapy \& radiation as per standard practice at MSKCC, which is induction chemotherapy for approximately 3 weeks, followed by concurrent chemoradiotherapy. A commonly used regimen is weekly carboplatin (AUC 2) with paclitaxel (50 mg/m2) \& radiation consisting of 5040 cGy over 28 fractions. Patients in this study will undergo assessments at three time points (at baseline, after induction chemotherapy, \& post-treatment.) At baseline, all patients will complete the functional assessment, dysphagia scale, \& Mini- Nutritional Assessment (MNA). According to the baseline MNA score, patients will be categorized as normal nutrition, at risk for malnutrition, or malnourished \& receive the appropriate intervention."
Memorial Sloan Kettering Cancer Center, New York
Memorial Sloan Kettering West Harrison (Consent Only), Harrison
Memorial Sloan Kettering Cancer Center @ Suffolk (Consent Only), Commack
Memorial Sloan Kettering Cancer Center at Commack (Consent Only), Commack
Memorial Sloan Kettering Cancer Center at Basking Ridge (Consent Only), Basking Ridge
Memorial Sloan Kettering Monmouth (Consent Only), Middletown
Memorial Sloan Kettering Bergen (Consent only), Montvale
Memorial Sloan Kettering Cancer Center
OTHER